Drug intelligence / Profile preview

Bloatnil Vet

Development stage: Unknown
Lead developer: Navana Pharmaceuticals
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Bloatnil Vet is a veterinary gastrointestinal preparation developed by Navana Pharmaceuticals for the treatment of bloat and tympany in livestock, including cattle, buffalo, sheep, and goats. It is a fixed-dose combination of simethicone, an anti-foaming agent, and dill oil, which possesses carminative properties. Simethicone works by reducing the surface tension of gas bubbles in the rumen, causing them to coalesce into larger bubbles that can be easily expelled. Dill oil helps prevent gas formation in the intestines and aids in its expulsion, providing rapid relief from abdominal distension and discomfort.

Brand names: Bloatnil Vet
Other names: Simethicone + Dill OilSimethicone and Dill Oil

Beyond the preview

Go deeper on Bloatnil Vet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bloatnil Vet.